Studies reporting blood levels of the omega-3 polyunsaturated fatty acids, eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA), were systematically identified in order to …

Several nutrition, food and dietary compounds have been suggested to be involved in the
onset and maintenance of depressive disorders and in the severity of depressive symptoms …

The changing of omega‐6/omega‐3 polyunsaturated fatty acids (PUFA) in the food supply of
Western societies occurred over the last 150 years is thought to promote the pathogenesis of …

Gene-environment interactions impact the development of neuropsychiatric disorders, but
the relative contributions are unclear. Here, we identify gut microbiota as sufficient to induce …

Background Diabetes as a common chronic disease leads to several serious disabilities and
complications. Patients with type 2 diabetes are involved with psychological and sleep …

Chronic obstructive pulmonary disease (COPD) is the third-leading cause of mortality
globally, significantly affecting people over 40 years old. COPD is often comorbid with mood …

Walnuts contain a number of potentially neuroprotective compounds like vitamin E, folate,
melatonin, several antioxidative polyphenols and significant amounts of ω-3 fatty acids. The …

Depression is a serious mental and mood disorder with global health and economic burden.
This burden may be overwhelming in low income countries, although there are insufficient …

Background In the general population, a higher omega‐3 polyunsaturated fatty acids intake
is associated with lower levels of several psychological symptoms, especially depression …

In 2016, the first worldwide n3 PUFA status map was published using the Omega-3 Index
(O3I) as standard biomarker. The O3I is defined as the percentage of EPA+ DHA in red …